Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development

被引:54
|
作者
Moraes, Gleiciane Leal [1 ]
Gomes, Guelber Cardoso [1 ,2 ]
Monteiro de Sousa, Paulo Robson [1 ]
Alves, Claudio Nahum [1 ]
Govender, Thavendran [3 ]
Kruger, Hendrik G. [3 ]
Maguire, Glenn E. M. [3 ]
Lamichhane, Gyanu [4 ]
Lameira, Jeronimo [1 ,2 ]
机构
[1] Fed Univ Para, Inst Ciencias Exatas & Nat, Lab Planejamento Farmacos, BR-66075110 Belem, Para, Brazil
[2] Fed Univ Para, Inst Ciencias Biol, BR-66075110 Belem, Para, Brazil
[3] Univ KwaZulu Natal, Sch Hlth Sci, Catalysis & Peptide Res Unit, Durban, South Africa
[4] Johns Hopkins Univ, Sch Med, Taskforce Study Resistance Emergence & Antimicrob, Baltimore, MD 21231 USA
关键词
TB; Homology modelling; Peptidoglycan; Drug design; UDP-N-ACETYLGLUCOSAMINE; L-ALANINE LIGASE; ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE MURB; ALANYL-D-GLUTAMATE; ENOLPYRUVYL TRANSFERASE MURA; ANGSTROM CRYSTAL-STRUCTURE; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; ADDING ENZYME; PHOSPHOGLUCOSAMINE MUTASE;
D O I
10.1016/j.tube.2015.01.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculosis (TB) is the second leading cause of human mortality from infectious diseases worldwide. The WHO reported 1.3 million deaths and 8.6 million new cases of TB in 2012. Mycobacterium tuberculosis (M. tuberculosis), the infectious bacteria that causes TB, is encapsulated by a thick and robust cell wall. The innermost segment of the cell wall is comprised of peptidoglycan, a layer that is required for survival and growth of the pathogen. Enzymes that catalyse biosynthesis of the peptidoglycan are essential and are therefore attractive targets for discovery of novel antibiotics as humans lack similar enzymes making it possible to selectively target bacteria only. In this paper, we have reviewed the structures and functions of enzymes GlmS, GlmM, GlmU, MurA, MurB, MurC, MurD, MurE and MurF from M. tuberculosis that are involved in peptidoglycan biosynthesis. In addition, we report homology modelled 3D structures of those key enzymes from M. tuberculosis of which the structures are still unknown. We demonstrated that natural substrates can be successfully docked into the active sites of the GlmS and GlmU respectively. It is therefore expected that the models and the data provided herein will facilitate translational research to develop new drugs to treat TB. (C) 2015 Published by Elsevier Ltd.
引用
收藏
页码:95 / 111
页数:17
相关论文
共 50 条
  • [41] Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
    Ioerger, Thomas R.
    O'Malley, Theresa
    Liao, Reiling
    Guinn, Kristine M.
    Hickey, Mark J.
    Mohaideen, Nilofar
    Murphy, Kenan C.
    Boshoff, Helena I. M.
    Mizrahi, Valerie
    Rubin, Eric J.
    Sassetti, Christopher M.
    Barry, Clifton E., III
    Sherman, David R.
    Parish, Tanya
    Sacchettini, James C.
    PLOS ONE, 2013, 8 (09):
  • [42] Advances in Computational Studies of Potential Drug Targets in Mycobacterium tuberculosis
    Alladi, Subha Mahadevi
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1062 - 1074
  • [43] Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon
    Bhat, Zubair Shanib
    Rather, Muzafar Ahmad
    Maqbool, Mubashir
    Ahmad, Zahoor
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 1733 - 1747
  • [44] Prioritizing genomic drug targets in pathogens:: Application to Mycobacterium tuberculosis
    Hasan, Samiul
    Daugelat, Sabine
    Rao, P. S. Srinivasa
    Schreiber, Mark
    PLOS COMPUTATIONAL BIOLOGY, 2006, 2 (06) : 539 - 550
  • [45] Chemical probes for accelerating the analysis of drug targets in Mycobacterium tuberculosis
    Beatty, Kimberly
    Dearing, Hailey
    Levine, Samantha
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S147 - S147
  • [46] Cofactor Biosynthetic Pathways in Mycobacterium tuberculosis as Potential Drug Targets
    Pandey, Shilpika
    Gaur, Sarthak
    Topno, Neha
    Chopra, Sidharth
    Dasgupta, Arunava
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2014, 10 (02) : 97 - 108
  • [47] STRUCTURAL FEATURES OF THE EXOCELLULAR POLYSACCHARIDES OF MYCOBACTERIUM-TUBERCULOSIS
    LEMASSU, A
    DAFFE, M
    BIOCHEMICAL JOURNAL, 1994, 297 : 351 - 357
  • [48] Unusual inorganic pyrophosphatase from Mycobacterium tuberculosis: from structural and functional features to effective inhibitors
    Romanov, R.
    Vainonen, L.
    Shuvalov, M.
    Yanvarev, D.
    Rodina, E.
    FEBS OPEN BIO, 2018, 8 : 212 - 212
  • [49] Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs
    Nunes, Jose E. S.
    Duque, Mario A.
    de Freitas, Talita F.
    Galina, Luiza
    Timmers, Luis F. S. M.
    Bizarro, Cristiano V.
    Machado, Pablo
    Basso, Luiz A.
    Ducati, Rodrigo G.
    MOLECULES, 2020, 25 (06):
  • [50] NOX enzymes as novel targets for drug development
    J. David Lambeth
    Karl-Heinz Krause
    Robert A. Clark
    Seminars in Immunopathology, 2008, 30 : 339 - 363